5月15日，诺诚健华（09969）早盘股价上涨5.53%，报9.92港元。公司一季度实现总营收3.81亿元，同比增长129.92%，核心产品奥布替尼销售收入达3.11亿元，同比增长89.22%。浦银国际表示，奥布替尼销售表现强劲，好于预期。管理层将全年奥布替尼收入增速从30%上调至35%，预计MZL适应症贡献占比将提升至50%。免责声明：本文内容由开放的智能模型自动生成，仅供参考。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.